Key residues in the VDAC2-BAK complex can be targeted to modulate apoptosis.

Area of Science:

• Cell Biology
• Molecular Biology
• Biochemistry

Background:

• The intrinsic apoptosis pathway is executed by BAK and BAX, which permeabilize the mitochondrial outer membrane.
• VDAC2, a mitochondrial channel protein, is essential for BAK and BAX localization to mitochondria for apoptosis.
• While interactions with pro-survival BCL-2 proteins are understood, the BAK-VDAC2 interaction remains largely undefined.

Purpose of the Study:

• To define the molecular interactions between BAK and VDAC2.
• To identify specific residues involved in the BAK-VDAC2 interaction.
• To explore the potential of targeting this interaction for therapeutic interventions.

Main Methods:

• Deep scanning mutagenesis was employed to probe the BAK-VDAC2 interface.
• Cysteine linkage and obstructive labeling were used to identify key residues.
• Mutational analysis of BAK and VDAC2 residues was performed to assess interaction and apoptotic activity.

Main Results:

• Specific residues in the BH3 domain and hydrophobic groove of BAK were found to be critical for VDAC2 interaction.
• Mutations in a cytosol-exposed region of VDAC2 stabilized BAK interaction and inhibited apoptosis.
• The study successfully mapped key residues governing the BAK-VDAC2 interaction.

Conclusions:

• The VDAC2-BAK interaction site is a potential therapeutic target.
• Targeting this interaction could modulate BAK-mediated apoptosis in diseases characterized by excessive cell death.
• This interaction can be leveraged to promote apoptosis for cancer therapy.